260 related articles for article (PubMed ID: 18506846)
1. Hypoxia-inducible factor 1 and cancer pathogenesis.
Semenza GL
IUBMB Life; 2008 Sep; 60(9):591-7. PubMed ID: 18506846
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
Semenza GL
Semin Cancer Biol; 2009 Feb; 19(1):12-6. PubMed ID: 19114105
[TBL] [Abstract][Full Text] [Related]
3. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.
Haase VH
Kidney Int; 2006 Apr; 69(8):1302-7. PubMed ID: 16531988
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
5. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
Zhang H; Gao P; Fukuda R; Kumar G; Krishnamachary B; Zeller KI; Dang CV; Semenza GL
Cancer Cell; 2007 May; 11(5):407-20. PubMed ID: 17482131
[TBL] [Abstract][Full Text] [Related]
6. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
7. Energy regulation: HIF MXIes it up with the C-MYC powerhouse.
Sutphin PD; Giaccia AJ; Chan DA
Dev Cell; 2007 Jun; 12(6):845-6. PubMed ID: 17543856
[TBL] [Abstract][Full Text] [Related]
8. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
9. HIF-1 mediates the Warburg effect in clear cell renal carcinoma.
Semenza GL
J Bioenerg Biomembr; 2007 Jun; 39(3):231-4. PubMed ID: 17551816
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
11. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
12. n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems.
Kimura M; Takabuchi S; Tanaka T; Murata M; Nishi K; Oda S; Oda T; Kanai M; Fukuda K; Kizaka-Kondoh S; Adachi T; Takabayashi A; Semenza GL; Hirota K
Biochem J; 2008 Apr; 411(1):97-105. PubMed ID: 18047470
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
Krishnamachary B; Zagzag D; Nagasawa H; Rainey K; Okuyama H; Baek JH; Semenza GL
Cancer Res; 2006 Mar; 66(5):2725-31. PubMed ID: 16510593
[TBL] [Abstract][Full Text] [Related]
14. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
Kaelin WG
Biochem Biophys Res Commun; 2005 Dec; 338(1):627-38. PubMed ID: 16153592
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL
Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178
[TBL] [Abstract][Full Text] [Related]
16. Regulation of metabolism by hypoxia-inducible factor 1.
Semenza GL
Cold Spring Harb Symp Quant Biol; 2011; 76():347-53. PubMed ID: 21785006
[TBL] [Abstract][Full Text] [Related]
17. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells.
Kwon SJ; Song JJ; Lee YJ
Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378
[TBL] [Abstract][Full Text] [Related]
18. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.
Kaelin WG
Nat Rev Cancer; 2008 Nov; 8(11):865-73. PubMed ID: 18923434
[TBL] [Abstract][Full Text] [Related]
19. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
[TBL] [Abstract][Full Text] [Related]
20. Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.
Roberts AM; Ohh M
Curr Opin Oncol; 2008 Jan; 20(1):83-9. PubMed ID: 18043261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]